Since 1992, the GB West lecture has been delivered by a distinguished member of the Society who has contributed significantly to the field of Histamine research and is in honour of Geoff West one of the founders of the EHRS.
Geoff West the orator
1992:
W. Schunack (Germany) Highly potent and selective ligands for histamine receptor subtypes
L.J. Brandes (Canada) Intracellular histamine receptors – The new frontier
1993:
Roberto Levi (USA) Histamine, the heart of the matter
1994:
T. Watanabe (Japan) Histaminergic neuron system in brain: recent advances
1995:
Walter Schunack (Germany) Design of H3-receptor agonists and antagonists
1996:
M.A. Kaliner (USA) The role of allergy in asthma – Implications for proper asthma management
1997:
Eddy Neugebauer (Germany) Histamine and antihistamine drugs in septic shock
1998:
Fred Pearce (UK) Mast cell heterogeneity
1999:
Madeleine Ennis (UK) Clinical significance of mast cell heterogeneity
2000:
W. Lorenz (Germany) Paradigms in histamine research: many controversies – many solutions
2001:
Helmut Haas (Germany) Histamine’s Wake
2002:
GR Gannellin (UK) Getting away from histamine
2003:
S.T. Holgate (UK) The role of chronic inflammation and remodelling in the pathogenesis of persistent asthma
2004:
P. Mannaioni (Italy) The riddle of the mast cell receptors in the immune response
2005:
Marija Carman-Krzan (Slovenia) My journey with histamine from the cardiovascular system to the brain
2006:
Andras Falus (Hungary) Histamine and systems biology; genes and genomics beyond genes
2007:
Rob Leurs (The Netherlands) And then there were four…
2008:
John Bienenstock (Canada) Mast cells, nerves and IgE
2009:
Fritz Melchers (Germany) Flexibilities within and around hematopoietic cell development
2010:
Jean-Charles Schwartz (France) Clinical applications of pitolisant (BF2.649), an inverse agonist at the H3 receptor
2011:
Robin Thurmond (USA) The role of the Histamine H4 receptor in allergy and inflammation
2012:
Peter Bradding (UK) Interactions between mast cells and structural airway cells in the pathogenesis of asthma
2013:
Jean-Charles Schwartz (France) Clinical trials with Pitolisant (WAKIX): a wake promoting H3 receptor inverse agonist
2014:
Satoshi Tanaka (Japan) Histamine synthesis and its functions in murine mast cells
2015:
Emannuela Masini (Italy) Histamine and Relaxin: an intriguing connection
2016:
Patrizio Blandina (Italy) The role of histamine in the memory of emotionally-salient experiences
2017:
Katzuhiko Yanai (Japan) The functional significance of the histaminergic neuronal system: Lessons from gene knockout mice and positron emission tomography
2018:
Nick Carruthers (USA) Three out of four: A 25 year relationship with histamine receptors
2019:
Francesca Levi-Schaffer (Israel) Inhibition activation or activated inhibition of mast cells and eosinophils: which weapon is better to fight allergic diseases?
2022:
Wolfgang Bäumer (Germany) Histamine in atopic dermatitis, particularly animal models of atopic dermatitis